About VDPHL01 - Our Pipeline | Veradermics | Revolutionizing Dermatology Solutions
VDPHL01, if approved, is poised to be the first and only extended-release oral minoxidil designed specifically for women and men with pattern hair loss – the largest aesthetics condition worldwide, with no new prescription therapies in nearly 30 years, and no oral prescription therapies approved by the FDA for women.| Veradermics
